The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
ESOT is excited to announce the release of the second EURO-KEP newsletter, marking another important step towards a more connected and collaborative approach to kidney exchange in Europe. The EURO-KEP project, proudly supported by ESOT, is working to establish a sustainable cross-border kidney exchange programme that enhances opportunities for living donation and improves equity in
The presence of anti-human leukocyte antigen (anti-HLA) antibodies defines transplant candidates as sensitised, a condition that affects access to transplantation, increasing waiting times and mortality rates. Following transplantation, sensitised patients have higher risk of antibody-mediated rejection (AMR) and graft failure when their anti-HLA antibodies are specific to the donor (DSA). Not all DSAs are equally
We are thrilled to unveil the list of outstanding transplant centres selected to host participants of the ESOT Centre of Preceptorship (CoP) for the 2025 programme cycle.
ESOT has announced the appointment of new board members to its European Kidney Transplant Association (EKITA) for the 2025–2029 term. As one of ESOT’s key Organ Expert Sections, EKITA provides a dedicated platform for advancing kidney transplantation across Europe. Its mission includes fostering scientific exchange, promoting education and research, developing guidelines, and providing advisory input
Are you a YPT affiliate in good standing? Then this limited-time offer is for YOU. For just €750, you get: ✔️ Full Masterclass Access – all scientific sessions, coffee breaks, lunches, gala dinner, meeting bag & certificate ✔️ 5 Nights at Hilton Kozyatağı Hotel (B&B) – check-in 13 Sept, check-out 18 Sept ✔️ Airport Transfers
We are proud to announce that the Living Donation Kidney Transplantation Specialty Symposium by EKITA has been officially accredited by the European Accreditation Council for Continuing Medical Education (EACCME®). ➡️ The event has been awarded 11.0 European CME credits (ECMEC®s). We look forward to welcoming you to Prague in November. ℹ️ https://esot.org/esot-events/ekita-meeting-2025/
ESOT is excited to announce the launch of its Centres of Preceptorship (CoP) initiative and invites transplant centres from across Europe to apply to become official hosts for the programme. This innovative project aims to establish a Europe-wide network of centres that provide education, mentorship, and training in the management of sensitised kidney transplant recipients
EKITA, the European Kidney Transplant Section of ESOT, would like to announce a call for nominations for three new Board members. The new EKITA Board Members will hold office for four years (2025-2029), starting in September 2025. All ESOT/EKITA affiliates are eligible to submit their applications for the positions. You may nominate yourself or a
Are you preparing for the EBSQ Examination in Transplant Surgery? Don’t miss your chance to join the 16th Preparatory Course, taking place on 27-28 March 2025 in the dynamic city of Istanbul, Turkey! Registration Deadline: 15 March 2025 Organised by the UEMS Division of Transplant Surgery, this highly sought-after course provides a comprehensive review of
This webinar will feature leading experts and patient voices who will delve into the scientific, clinical, and human aspects of desensitisation. Attendees will gain a comprehensive understanding of HLA sensitisation, learn to identify which patients could benefit from desensitisation protocols, and hear firsthand experiences of patients navigating this complex journey. A unique dialogue between a
